Gossamer Bio's stock falls 64% on findings for Phase 2 study for hypertension drug | Rich FXM

Gossamer Bio's stock falls 64% on findings for Phase 2 study for hypertension drug

This entry was posted by admin on December 6, 2022 at 2:01 pm

Gossamer Bio's stock falls 64% on findings for Phase 2 study for hypertension drug

Click here to read the full article

10,094

Like

Save

Tags: Bio&#039s, Drug, Falls, findings, Gossamer, hypertension, phase, Stock, study
Categories: Breaking

Comments

Comments are disabled for this post.

Copyright © RichFXM.com. Back to Forex Search